Insider Trading June 5, 2026 04:55 PM

HIVE Digital Director Divests Shares Amid Analyst Revisions

Susan McGee's recent sale coincides with a wave of price target adjustments from major firms, highlighting mixed market sentiment around the company's cloud expansion.

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
HIVE

Susan B. McGee, a director at HIVE Digital Technologies Ltd. (NASDAQ:HIVE), executed a sale of 16,700 common shares on June 3, 2026, according to a recent SEC filing. The transaction was valued at $74,315, with each share sold at $4.45. This sale follows a period of significant analyst activity, where multiple firms have revised their price targets and ratings for HIVE, reflecting varying perspectives on the company's strategic developments and growth trajectory. The article examines the implications of this insider transaction and the broader analyst consensus surrounding HIVE's business prospects.

HIVE Digital Director Divests Shares Amid Analyst Revisions
HIVE
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Susan B. McGee sold 16,700 shares of HIVE Digital Technologies Ltd. on June 3, 2026, at $4.45 per share, totaling $74,315.
  • Multiple analyst firms have revised their price targets for HIVE, reflecting varying perspectives on the company's cloud expansion and HPC business growth.
  • The sale coincides with a period of mixed analyst sentiment, with some firms raising targets significantly while others maintain conservative ratings.

Susan B. McGee, a director at HIVE Digital Technologies Ltd. (NASDAQ:HIVE), executed a sale of 16,700 common shares on June 3, 2026, according to a recent SEC filing. The transaction was valued at $74,315, with each share sold at $4.45. This sale follows a period of significant analyst activity, where multiple firms have revised their price targets and ratings for HIVE, reflecting varying perspectives on the company's strategic developments and growth trajectory.

The reported sale price of $4.45 per share represents C$6.18 Canadian dollars per share, which was converted to U.S. dollars using an exchange rate of U.S. $1.00 to C$1.3884, as reported by the Bank of Canada on the transaction date.

Following this transaction, Ms. McGee directly owns 208,300 common shares in HIVE Digital Technologies Ltd.

In other recent news, Hive Digital Technologies has seen multiple analyst firms adjust their stock price targets, reflecting various strategic developments. Keefe, Bruyette & Woods increased their price target to $5.00 from $3.00, maintaining a Market Perform rating, citing the company’s progress toward $200 million in cloud annual recurring revenue by year-end. B.Riley raised its price target to $8.00 from $5.00, highlighting the growth potential of Hive’s BUZZ HPC business, which is projected to achieve $660 million in contracted annual recurring revenue by 2028. Rosenblatt also adjusted its price target to $5.50 from $5.00, maintaining a Buy rating despite noting softer-than-expected fiscal fourth-quarter results. H.C. Wainwright reiterated a Buy rating with a $7.00 price target, pointing to potential upside if Hive successfully executes multi-year contracts for GPU deployments targeted for 2026. Cantor Fitzgerald raised their price target to $4.60 from $3.00, valuing the company’s cloud business based on its 2027 revenue estimate. These developments indicate a range of expectations for Hive Digital Technologies’ growth trajectory.

Risks

  • Softer-than-expected fiscal fourth-quarter results noted by Rosenblatt indicate potential short-term performance challenges.
  • Execution risk associated with multi-year contracts for GPU deployments targeted for 2026, as highlighted by H.C. Wainwright.
  • Currency fluctuation risk, as the transaction involved converting Canadian dollars to U.S. dollars, impacting the final sale value.

More from Insider Trading

Nano Nuclear Energy Director Disposes of All Shares Following RSU Vesting Jun 5, 2026 Beta Bionics Director Jones Christy Executes Pre-Arranged Stock Sale Jun 5, 2026 MiNK Therapeutics Director Disposes of $19,141 in Common Stock Jun 5, 2026 Beta Bionics Executive Sells Shares Under Pre-Arranged Plan Jun 5, 2026 Outset Medical CFO Executes Tax-Related Stock Sale Amid Strategic Focus Jun 5, 2026